usage of PLGA HNPs using cellpenetrating peptides could delivery almost 100% of siRNA safely inside the nucleus resulting in site targeted gene silencing in cancer cells
PEGylation. A large number of preclinical studies suggest that ligand-targeted nanoparticles can permit tissue-specific intracellular delivery of RNAi or gene therapy agents. A portfolio of therapeutics that utilize
Background/Aims: Vectors derived from adeno-associated viruses (AAVs) have become important gene delivery tools for the treatment of many inherited pulmonary diseases, such as cystic fibrosis and α1-antitrypsin…
Carbon nanotubes (CNTs) are quite attractive as drug delivery vehicles for targeted organ, tissue and systemic therapy. However, how these drug-laden CNTs interact with components of the immune system ... mediated drug…
α6β4(+) epithelial cells significantly rescued defects in Cl(-) transport. Therefore, targeting the α6β4(+) epithelial population via either gene delivery or progenitor cell-based reconstitution represents a potential…
drug carrier candidate, and justified through the most potential drug delivery systems i.e. as protein-drug nanoconjugates and green nanoparticle synthesis approach. For this purpose, a study was conducted ... fetuin-A…
Skin delivery of drugs is an alternative approach for the treatment of dermatological diseases due to its superiorities including, targeting the site of infection, reduction of the risk of systemic ... target layers of…
nanoparticles with diameter in the range of 1-100 nm could be used as targets delivery system for drugs (e.g Rivastigmine) to overcome the blood-brain barrier
improved drug delivery strategies using existing drugs formulating into biodegradable microspheres by optimizing the size of the particles which can be used for lung targeting. Carbopol microspheres of Methotrexate…
limited medical impact because of delivery problems. In this presentation, we demonstrate that a delivery vehicle, termed DARTs (DNA Assembled Recombinant Transcription factors), can for the first time deliver…
Unexpurgated and site targeted delivery of small interfering RNA (siRNA) that can silence the expression of disease related genes is still a great challenge in nano-gene delivery field. siRNA ... PLGA HNPs using CPPs…
hybrid nanoparticulate drug delivery system (DDS) consisting of a liposomal core coated with alternate layers of alginate and chitosan was developed by our group for the purpose of delivering Bone ... first by ensuring…
Drug delivery and gene transfection systems often use solid nano-particles (NPs) as carriers. While this is not as efficient as the use of viral vectors, there is an increasing ... discomfort. Upon entry into the cell…
destruction. The first one was action of cytotoxic drugs. Because the NP was triple targeted, it augments the uptake of NP by cancer cells thus resulting in the damage ... triggers the release of drug from PLGA NPs and…
treat disease, have established that gene delivery vehicles based on viruses are efficient, safe, and capable of therapeutic gene transfer to numerous target cells and tissues. In particular, nanoscale vehicles…
This presentation will highlight the use of imaging biomarkers to facilitate and optimize drug delivery in preclinical and clinical settings. A brief history of the field will be presented, followed ... engagement…
China mainly aims at enhancing the efficacy and safety through improving physicochemical properties, targeted delivery or controlled release mechanisms. Furthermore, the development of nanoformulation for pesticides…
with activated folic acid as a navigational molecule is the critical phase for targeted drug delivery. Attachments were verified using FTIR and NMR which confirmed the formation of non-covalent ... temperature dependent…
specific to cancer cells. As a result, the formulation development of delivery systems containing anticancer agents capable of targeting tumor cells is highly desired. Our research aimed to formulate albumin
Efforts toward the targeted delivery of therapeutic agents to tumors remain an important challenge for clinical development due to severe side effects related to insufficient drug accumulation in solid tumors…
anti-cancer drug such as paclitaxel that specifically target CD44+ overexpressing tumor are synthesised which can act as promising drug delivery vehicle
size and narrow size distribution are desirable for a variety of applications like targeted drug delivery, medical imaging magnetic data storage, and other biomedical applications, magnetic data storage, etc…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.